2,6-Dimethyl-N-[3-[5-methyl-2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]pyridine-3-carboxamide

ID: ALA4536860

PubChem CID: 155548345

Max Phase: Preclinical

Molecular Formula: C25H24N8O

Molecular Weight: 452.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(C(=O)Nc2cccc3c(-c4nc(Nc5cnn(C)c5)ncc4C)c[nH]c23)c(C)n1

Standard InChI:  InChI=1S/C25H24N8O/c1-14-10-27-25(30-17-11-28-33(4)13-17)32-22(14)20-12-26-23-19(20)6-5-7-21(23)31-24(34)18-9-8-15(2)29-16(18)3/h5-13,26H,1-4H3,(H,31,34)(H,27,30,32)

Standard InChI Key:  ZWZPVJXSWZWJLP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   27.8367   -8.8900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8356   -9.7137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5478  -10.1226    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.2616   -9.7132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2587   -8.8864    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.5460   -8.4770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9740  -10.1207    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.6811   -9.7110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5377   -7.6548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1211   -6.3943    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.8711   -7.1764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1248   -8.4775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9425   -6.3919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1974   -7.1726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9978   -7.3423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5441   -6.7323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2886   -5.9499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4888   -5.7838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4264  -10.0369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9722   -9.4287    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.5625   -8.7216    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.7635   -8.8929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8936   -7.9745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2340   -5.0074    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.7791   -4.3985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5243   -3.6220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5789   -4.5661    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0721   -3.0175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8178   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0172   -2.0735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4714   -2.6873    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.7285   -3.4607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1866   -4.0724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7614   -1.3028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  9 14  1  0
 13 10  1  0
 10 11  1  0
 11  9  2  0
  6  9  1  0
  1 12  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  8 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22  8  2  0
 21 23  1  0
 18 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
 26 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 26  1  0
 32 33  1  0
 30 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4536860

    ---

Associated Targets(Human)

JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 452.52Molecular Weight (Monoisotopic): 452.2073AlogP: 4.67#Rotatable Bonds: 5
Polar Surface Area: 113.41Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.24CX Basic pKa: 5.24CX LogP: 3.38CX LogD: 3.38
Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.36Np Likeness Score: -1.64

References

1. Su Q, Banks E, Bebernitz G, Bell K, Borenstein CF, Chen H, Chuaqui CE, Deng N, Ferguson AD, Kawatkar S, Grimster NP, Ruston L, Lyne PD, Read JA, Peng X, Pei X, Fawell S, Tang Z, Throner S, Vasbinder MM, Wang H, Winter-Holt J, Woessner R, Wu A, Yang W, Zinda M, Kettle JG..  (2020)  Discovery of (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor.,  63  (9): [PMID:32297743] [10.1021/acs.jmedchem.9b01392]

Source